Guidelines emphasize that pharmacotherapy for pediatric obesity should be used in conjunction with what?

• A. Intensive behavioral interventions
• B. Surgical planning
• C. Diet only
• D. Medication only

Answer: (A)

Pharmacotherapy for pediatric obesity is intended to complement a structured, multi-component treatment approach rather than stand alone. Medications can aid weight loss, but lasting results come from intensive behavioral interventions that target eating patterns, physical activity, routines, and family support with regular follow-up. This combination addresses the behaviors and environment driving weight gain and supports sustainable change. Options like planning surgery are reserved for specific, more severe cases after other strategies have been tried; relying on diet alone misses the crucial behavioral and activity components, and medications without this behavioral framework are less effective in the long term.